Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹27,829.8
₹59,137 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,699.7
₹33,729 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹763.5
₹6,920 Cr
Pharmaceuticals & Drugs
₹423.9
₹6,672 Cr
Pharmaceuticals & Drugs
₹370.7
₹3,383 Cr
Pharmaceuticals & Drugs
₹269.0
₹3,010 Cr
Pharmaceuticals & Drugs
₹91.7
₹2,355 Cr
Pharmaceuticals & Drugs
₹689.0
₹393 Cr
Pharmaceuticals & Drugs
₹68.8
₹195 Cr
Pharmaceuticals & Drugs
₹38.4
₹187 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,699.7
₹4,973 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹423.9
₹4,108 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹370.7
₹2,477 Cr
Pharmaceuticals & Drugs
₹763.5
₹1,906 Cr
Pharmaceuticals & Drugs
₹269.0
₹707 Cr
Pharmaceuticals & Drugs
₹91.7
₹224 Cr
Pharmaceuticals & Drugs
₹38.4
₹111 Cr
Pharmaceuticals & Drugs
₹27,829.8
₹6,714 Cr
Pharmaceuticals & Drugs
₹689.0
₹316 Cr
Pharmaceuticals & Drugs
₹68.8
₹428 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,699.7
₹974 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹423.9
₹323 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹763.5
₹242 Cr
Pharmaceuticals & Drugs
₹370.7
₹199 Cr
Pharmaceuticals & Drugs
₹269.0
₹151 Cr
Pharmaceuticals & Drugs
₹91.7
₹144 Cr
Pharmaceuticals & Drugs
₹38.4
₹5 Cr
Pharmaceuticals & Drugs
₹27,829.8
₹1,509 Cr
Pharmaceuticals & Drugs
₹689.0
₹-15 Cr
Pharmaceuticals & Drugs
₹68.8
₹4 Cr

You may also like the below Video Courses